edwards lifesciences corp (EWL:Berlin)
Transactions by EDWARDS LIFESCIENCES CORP (EWL) in the last 6 months
CardioKinetix, Inc. announced that it will receive $37,709,453 in funding on December 5, 2014. The company will issue series F preferred stock and warrants in the transaction. Preferred stock can be convertible into common stock of the company. Each warrant entitles the holder to acquire a series F preferred stock. The company will issue securities pursuant to exemption provided under Regulation D.
Lexington Partners Inc.
New Leaf Venture Partners
SV Life Sciences Advisers, LLC
SV Life Sciences Fund V
Tekla Capital Management LLC
Tekla Healthcare Investors
Tekla Life Sciences Investors
U.S. Venture Partners
Edwards Lifesciences Corp. (NYSE:EW) announces a share repurchase program. Under the program, the company will repurchase up to $750 million worth of its outstanding shares.
The Board of Directors of Edwards Lifesciences Corp. has authorized a buyback plan on July 29, 2014.
On July 1, 2014, the company initiated a Market Repurchase.
From July 29, 2014 to September 30, 2014, the company has repurchased 0 shares, representing 0% for $0 million. With this, the ...
|CR Bard Inc||$168.40 USD||-0.70|
|Endo International PLC||$73.16 USD||+1.06|
|Hologic Inc||$26.93 USD||+0.04|
|Intuitive Surgical Inc||$531.24 USD||+0.30|
|Mettler-Toledo International Inc||$304.33 USD||+1.45|
|View Industry Companies|